{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T15:07:18Z","timestamp":1761577638484,"version":"build-2065373602"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infection, Genetics and Evolution"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.meegid.2019.103966","type":"journal-article","created":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T02:07:32Z","timestamp":1563242852000},"page":"103966","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Signature of natural resistance in NS3 protease revealed by deep sequencing of HCV strains circulating in Iran"],"prefix":"10.1016","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9433-8752","authenticated-orcid":false,"given":"Lize","family":"Cuypers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marijn","family":"Thijssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arash","family":"Shakibzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ward","family":"Deboutte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamal","family":"Sarvari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farzaneh","family":"Sabahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehrdad","family":"Ravanshad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4620-6453","authenticated-orcid":false,"given":"Mahmoud Reza","family":"Pourkarim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.meegid.2019.103966_bb0005","doi-asserted-by":"crossref","DOI":"10.5812\/jjm.24965","article-title":"Analysis of naturally occurring resistant mutations to hepatitis C virus NS3 protease inhibitors: a preliminary study in south of Iran","volume":"8","author":"Afrasiabi","year":"2015","journal-title":"Jundishapur J. Microbiol."},{"issue":"1","key":"10.1016\/j.meegid.2019.103966_bb0010","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.11879","article-title":"Changing of HCV clade pattern in Iran; the possible means for something good","volume":"14","author":"Afzal","year":"2014","journal-title":"Hepat. Mon."},{"issue":"10","key":"10.1016\/j.meegid.2019.103966_bb0015","doi-asserted-by":"crossref","first-page":"670","DOI":"10.4254\/wjh.v10.i10.670","article-title":"Era of direct acting anti-viral agents for the treatment of hepatitis C","volume":"10","author":"Ahmed","year":"2018","journal-title":"World J. Hepatol."},{"issue":"8","key":"10.1016\/j.meegid.2019.103966_bb0020","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.guideline","article-title":"Recommendations for the clinical management of Hepatitis C in Iran: a consensus-based national guideline","volume":"16","author":"Alavian","year":"2016","journal-title":"Hepat. Mon."},{"key":"10.1016\/j.meegid.2019.103966_bb0025","doi-asserted-by":"crossref","first-page":"W364","DOI":"10.1093\/nar\/gkp455","article-title":"A standardized framework for accurate, high-throughput genotyping of recombinant and non-recombinant viral sequences","volume":"37","author":"Alcantara","year":"2009","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.meegid.2019.103966_bb0030","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1089\/cmb.2012.0021","article-title":"SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing","volume":"19","author":"Bankevich","year":"2012","journal-title":"J. Comput. Biol."},{"issue":"1","key":"10.1016\/j.meegid.2019.103966_bb0035","doi-asserted-by":"crossref","first-page":"8988","DOI":"10.1038\/s41598-018-26862-y","article-title":"Prevalence of single and multiple natural NS3, NS5A and NS5B resistance-associated substitutions in hepatitis C virus genotypes 1-4 in Italy","volume":"8","author":"Bertoli","year":"2018","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.meegid.2019.103966_bb0040","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/hep4.1310","article-title":"Who to test for hepatitis C virus in the Middle East and North Africa?: pooled analyses of 2,500 prevalence measures, including 49 million tests","volume":"3","author":"Chemaitelly","year":"2019","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.meegid.2019.103966_bb0045","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jviromet.2014.09.009","article-title":"A near-full length genotypic assay for HCV1b","volume":"209","author":"Cuypers","year":"2014","journal-title":"J. Virol. Methods"},{"issue":"9","key":"10.1016\/j.meegid.2019.103966_bb0050","doi-asserted-by":"crossref","first-page":"5018","DOI":"10.3390\/v7092857","article-title":"Genetic diversity and selective pressure in hepatitis C virus genotypes 1-6: significance for direct-acting antiviral treatment and drug resistance","volume":"7","author":"Cuypers","year":"2015","journal-title":"Viruses."},{"issue":"6","key":"10.1016\/j.meegid.2019.103966_bb0055","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/rmv.1895","article-title":"Impact of HCV genotype on treatment regimens and drug resistance: a snapshot in time","volume":"26","author":"Cuypers","year":"2016","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.meegid.2019.103966_bb0060","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.meegid.2017.05.007","article-title":"Exploring resistance pathways for first-generation NS3\/4A protease inhibitors boceprevir and telaprevir using Bayesian network learning","volume":"53","author":"Cuypers","year":"2017","journal-title":"Infect. Genet. Evol."},{"issue":"1","key":"10.1016\/j.meegid.2019.103966_bb0065","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12862-017-0913-3","article-title":"Implications of hepatitis C virus subtype 1a migration patterns for virus genetic sequencing policies in Italy","volume":"17","author":"Cuypers","year":"2017","journal-title":"BMC Evol. Biol."},{"issue":"6","key":"10.1016\/j.meegid.2019.103966_bb0070","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1080\/14656566.2018.1454428","article-title":"Protease inhibitor therapy for hepatitis C virus-infection","volume":"19","author":"de Leuw","year":"2018","journal-title":"Expert. Opin. Pharmacother."},{"issue":"W1","key":"10.1016\/j.meegid.2019.103966_bb0075","doi-asserted-by":"crossref","first-page":"W271","DOI":"10.1093\/nar\/gky349","article-title":"geno2pheno[ngs-freq]: a genotypic interpretation system for identifying viral drug resistance using next-generation sequencing data","volume":"46","author":"Doring","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.meegid.2019.103966_bb0080","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/cid\/civ894","article-title":"The impact of enhanced screening and treatment on hepatitis C in the United States","volume":"62","author":"Durham","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.meegid.2019.103966_bb0085","series-title":"Hepatitis C Virus NS5B Sequence-Based Genotyping Analysis of Patients From the Sharkia Governorate, Egypt","first-page":"e12706","volume":"13(12)","author":"Elsadek Fakhr","year":"2013"},{"issue":"6","key":"10.1016\/j.meegid.2019.103966_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157615","article-title":"Prevalence and trends of transfusion-transmissible viral infections among blood donors in south of Iran: an eleven-year retrospective study","volume":"11","author":"Farshadpour","year":"2016","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.meegid.2019.103966_bb0095","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.1128\/JCM.02209-14","article-title":"Reassessment of genotype 1 hepatitis C virus subtype misclassification by LiPA 2.0: implications for direct-acting antiviral treatment","volume":"52","author":"Guelfo","year":"2014","journal-title":"J. Clin. Microbiol."},{"issue":"7","key":"10.1016\/j.meegid.2019.103966_bb0100","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.37234","article-title":"Liver disease burden of hepatitis C virus infection in Iran and the potential impact of various treatment strategies on the disease burden","volume":"16","author":"Hajarizadeh","year":"2016","journal-title":"Hepat. Mon."},{"issue":"10178","key":"10.1016\/j.meegid.2019.103966_bb0105","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S0140-6736(18)32277-3","article-title":"Scaling up prevention and treatment towards the elimination of hepatitis C: a global mathematical model","volume":"393","author":"Heffernan","year":"2019","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.meegid.2019.103966_bb0110","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1093\/bioinformatics\/btv120","article-title":"IVA: accurate de novo assembly of RNA virus genomes","volume":"31","author":"Hunt","year":"2015","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.meegid.2019.103966_bb0115","doi-asserted-by":"crossref","first-page":"e7991","DOI":"10.5812\/hepatmon.7991","article-title":"Distribution of hepatitis C virus genotypes in Iranian chronic infected patients","volume":"13","author":"Jahanbakhsh Sefidi","year":"2013","journal-title":"Hepat. Mon."},{"issue":"12","key":"10.1016\/j.meegid.2019.103966_bb0120","article-title":"Prevalence of hepatitis C virus genotypes in Iranian patients: a systematic review and meta-analysis","volume":"14","author":"Khodabandehloo","year":"2014","journal-title":"Hepat. Mon."},{"issue":"8","key":"10.1016\/j.meegid.2019.103966_bb0125","first-page":"674","article-title":"Prevalence and trend of hepatitis C virus infection among blood donors in Iran: a systematic review and meta-analysis","volume":"18","author":"Khodabandehloo","year":"2013","journal-title":"J. Res. Med. Sci."},{"issue":"2","key":"10.1016\/j.meegid.2019.103966_bb0130","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jhep.2017.03.039","article-title":"Glecaprevir and pibrentasvir yield high response rates in patients with HCV genotype 1-6 without cirrhosis","volume":"67","author":"Kwo","year":"2017","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.meegid.2019.103966_bb0135","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s41598-017-18296-9","article-title":"The epidemiology of hepatitis C virus in Iran: systematic review and meta-analyses","volume":"8","author":"Mahmud","year":"2018","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.meegid.2019.103966_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17091416","article-title":"Detection of natural resistance-associated substitutions by ion semiconductor technology in HCV1b positive, direct-acting antiviral agents-naive patients","volume":"17","author":"Marascio","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"Suppl. 3","key":"10.1016\/j.meegid.2019.103966_bb0145","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1016\/j.ijid.2009.11.032","article-title":"Seroprevalence of hepatitis C virus: the first population-based study from Iran","volume":"14","author":"Merat","year":"2010","journal-title":"Int. J. Infect. Dis."},{"issue":"10","key":"10.1016\/j.meegid.2019.103966_bb0150","first-page":"1575","article-title":"The estimation of economic burden of hepatitis C virus infection in Iran","volume":"47","author":"Mohammadzadeh","year":"2018","journal-title":"Iran. J. Public Health"},{"issue":"10","key":"10.1016\/j.meegid.2019.103966_bb0155","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1007\/s00705-018-3920-9","article-title":"Prevalence of naturally occurring amino acid substitutions associated with resistance to hepatitis C virus NS3\/NS4A protease inhibitors in Sao Paulo state","volume":"163","author":"Moreira","year":"2018","journal-title":"Arch. Virol."},{"issue":"8","key":"10.1016\/j.meegid.2019.103966_bb0160","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3851\/IMP2964","article-title":"Baseline prevalence and emergence of protease inhibitor resistance mutations following treatment in chronic HCV genotype-1-infected individuals","volume":"20","author":"Nguyen","year":"2015","journal-title":"Antivir. Ther."},{"issue":"5","key":"10.1016\/j.meegid.2019.103966_bb0165","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/QAI.0000000000001628","article-title":"Transmission networks of HCV genotype 1a enriched with pre-existing polymorphism Q80K among HIV-infected patients with acute hepatitis C in Poland","volume":"77","author":"Parczewski","year":"2018","journal-title":"J. Acquir. Immun. Defic. Syndr."},{"issue":"9","key":"10.1016\/j.meegid.2019.103966_bb0170","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2019.24.9.1800227","article-title":"Increasing importance of European lineages in seeding the hepatitis C virus subtype 1a epidemic in Spain","volume":"24","author":"Perez","year":"2019","journal-title":"Euro Surveill."},{"issue":"10152","key":"10.1016\/j.meegid.2019.103966_bb0175","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0140-6736(18)31810-5","article-title":"Iran\u2019s hepatitis elimination programme is under threat","volume":"392","author":"Pourkarim","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.meegid.2019.103966_bb0180","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jcv.2015.02.005","article-title":"Prevalence of HCV NS3 pre-treatment resistance associated amino acid variants within a Scottish cohort","volume":"65","author":"Shepherd","year":"2015","journal-title":"J. Clin. Virol."},{"issue":"Suppl. 4","key":"10.1016\/j.meegid.2019.103966_bb0185","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/jvh.12476","article-title":"The present and future disease burden of hepatitis C virus infections with today\u2019s treatment paradigm - volume 3","volume":"22","author":"Sibley","year":"2015","journal-title":"J. Viral Hepat."},{"issue":"18","key":"10.1016\/j.meegid.2019.103966_bb0190","doi-asserted-by":"crossref","first-page":"e144","DOI":"10.1093\/nar\/gku739","article-title":"COMET: adaptive context-based modeling for ultrafast HIV-1 subtype identification","volume":"42","author":"Struck","year":"2014","journal-title":"Nucleic Acids Res."},{"issue":"38","key":"10.1016\/j.meegid.2019.103966_bb0195","doi-asserted-by":"crossref","first-page":"10790","DOI":"10.3748\/wjg.v21.i38.10790","article-title":"Epidemiology of hepatitis C virus in Iran","volume":"21","author":"Taherkhani","year":"2015","journal-title":"World J. Gastroenterol."},{"issue":"10","key":"10.1016\/j.meegid.2019.103966_bb0200","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1128\/JCM.00330-16","article-title":"Comparison of next-generation sequencing technologies for comprehensive assessment of full-length hepatitis C viral genomes","volume":"54","author":"Thomson","year":"2016","journal-title":"J. Clin. Microbiol."},{"issue":"3","key":"10.1016\/j.meegid.2019.103966_bb0205","first-page":"103","article-title":"Understanding hepatitis C virus drug resistance: clinical implications for current and future regimens","volume":"25","author":"Wyles","year":"2017","journal-title":"Topics Antiviral Med."},{"issue":"1","key":"10.1016\/j.meegid.2019.103966_bb0210","doi-asserted-by":"crossref","first-page":"vey007","DOI":"10.1093\/ve\/vey007","article-title":"Easy and accurate reconstruction of whole HIV genomes from short-read sequence data with shiver","volume":"4","author":"Wymant","year":"2018","journal-title":"Virus Evol."}],"container-title":["Infection, Genetics and Evolution"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134819301844?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134819301844?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T14:39:21Z","timestamp":1761575961000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567134819301844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":42,"alternative-id":["S1567134819301844"],"URL":"https:\/\/doi.org\/10.1016\/j.meegid.2019.103966","relation":{},"ISSN":["1567-1348"],"issn-type":[{"type":"print","value":"1567-1348"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Signature of natural resistance in NS3 protease revealed by deep sequencing of HCV strains circulating in Iran","name":"articletitle","label":"Article Title"},{"value":"Infection, Genetics and Evolution","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.meegid.2019.103966","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103966"}}